Prenatal exposure to low doses of the environmental contaminants polychlorinated biphenyls, or PCBs, change the developing brain in an area involved in metabolism, and some effects are apparent even two generations later, a new study finds.
In an encouraging development for consumers worried about antibiotics in their milk, a new Food and Drug Administration study showed little evidence of drug contamination after surveying almost 2,000 dairy farms.
Implanted stem cells reduced symptoms of disease during experiment, researchers say.
Researchers at Aalto University and University of Turku have revealed how obesity is associated with altered opioid neurotransmission in the brain.
People with poor physical fitness in their 40s may have accelerated brain aging by the time they hit 60.
A study reveals for the first time exactly how mutations associated with the most common form of inherited Alzheimer’s disease produce the disorder’s devastating effects.
Certain neurons act as conductors, suggesting possible therapies for disorders such as schizophrenia.
Tumor recurrence following a period of remission is the main cause of death in cancer. The ability of cancer cells to remain dormant during and following therapy, only to be reactivated at a later time, frequently with greater aggressiveness, is one of the least-understood aspects of the disease.
The new study describes in detail the loss of connectivity between two sets of neurons that prevents the formation of long-term memory.
Three startups are taking advantage of new technology to help patients get treatment for various diseases all over the world.
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
The United Nations is urging donors, organizations and countries fighting Ebola in West Africa not to give in to complacency as the death toll from the virus climbs toward 10,000.
Mouse studies may lead to development of human therapies.
The prevailing medical wisdom that Alzheimer's Disease has its origins in the brain has a radical and disputed rival with shocking implications for medicine's relentless efforts to forestall disease, ageing and death, according to a new review of the evidence.
Future treatments could bind to vulnerable site in viruses causing a variety of diseases.
New formula gauges 10-year risk of dying.
Sierra Leone's vice president has put himself in quarantine following the death from Ebola of one of his security guards.
Highlighting a potential target in the treatment of multiple sclerosis (MS) and Alzheimer’s disease, new research suggests that triggering a protein found on the surface of brain cells may help slow the progression of these and other neurological diseases.
Genetically engineered T memory stem cells (Tscm) can last more than 12 years in patients’ bodies, and can continually generate appropriate T cell armies for them, says an innovative study looking at two historic clinical trials.
Inflammation - the body's response to damaging stimuli - may have a protective effect against cardiovascular disease, according to a study published in the journal Lancet Diabetes and Endocrinology.
Study participants inhaled nicotine, yet they showed significantly different brain activity.
Researchers have designed a molecule that, if developed into a drug, could slow the progression of Parkinson's Disease.
A doctor who contracted the deadly Ebola virus and rode the subway system and dined out before he developed symptoms said the media and politicians could have done a better job by educating people on the science of it instead of focusing on their fears.
Scientists have used graphene to target and neutralize cancer stem cells while not harming other cells.
The bill granting the controversial techniques was passed Tuesday by the House of Lords, after being approved earlier this month by the House of Commons.